2型糖尿病患者を対象とした、SYR-472（100mg）とインスリンの併用に関する第4相無作為化二重盲検並行群間比較試験および第4相非盲検長期試験

基本情報

NCT ID

NCT02324569

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

240

治験依頼者名

Takeda

概要

The purposes of this study is to evaluate the efficacy and safety of SYR-472 when administered at a dose of 100 mg once weekly as an add-on to insulin therapy compared with placebo in patients with type 2 diabetes mellitus and inadequate glycemic control despite treatment with insulin preparations in addition to diet and/or exercise therapy; and to evaluate the long-term efficacy and safety of SYR-472 when administered at a dose of 100 mg once weekly as an add-on to insulin therapy in patients with type 2 diabetes mellitus and inadequate glycemic control despite treatment with insulin preparations in addition to diet and/or exercise therapy.

対象疾患

介入

依頼者（Sponsor）